Immediate Release Pain Management Gaining Prescribers as Experience Eases Safety Fears

(Nashua, NH) – As life expectancy in the developed world increases and populations age, the incidence and associated morbidity of chronic and acute pain are increasing, placing a higher level of emphasis on pain management as a quality-of-life issue for patients and their families. This issue is no more problematic than in the treatment for intractable cancer pain, commonly referred to as breakthrough cancer pain (BTcP). The combination of aging and the ability of medical treatment to prolong the lives of cancer patients paint an unfortunate picture of growing unmet need that several drug developers have been attempting to address.

Pain treatment for BTcP is focused on immediate release formulations that deliver fentanyl, a powerful opioid, via the oral or nasal mucosa. These routes offer the potential for rapid absorption while avoiding the effects of first pass metabolism. After an initial period of trepidation due to the potential side effects of fentanyl use, practitioners now recognize the rapid onset, relative reliability, and the general lack of patient discomfort when drugs are administered by the transmucosal route. We expect this market to experience healthy growth through 2020 as absorbable solid dosage technology is applied to existing drugs, and as similar formulations become an important route of administration for novel pain drugs.

Based on the growing acceptance of immediate release opioids for debilitating pain, developers are targeting alternative formulations and new pain market segments for future products. The market has caught the attention of generics firms seeking to profit from the growing need for improved pain management. As the competitive landscape evolves, we expect the level of technology acquisition to accelerate.

These finding are contained in a new report researched and written by Applied Data. Immediate Release Pain Management to 2020 is a comprehensive analysis of products, technology, and market participants in the immediate release pain management space. It consists of in-depth analyses, descriptions and evaluations of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in this evolving market.

More information is available at applieddata.org

Source: Applied Data Research

About Applied Data Research

Applied Data Research is a management consulting firm, assisting decision makers by providing comprehensive publications designed to reveal key relationships, patterns and trends affecting their businesses. These information tools contain comprehensive, timely, and insightful analysis and assessments, allowing users to make informed tactical and strategic decisions.

Contact:
Greg Stone
Applied Data Research
98 Amherst ST
Amherst, NH 03031 USA
Voice: 603-718-4564
grstone@applieddata.org
www.applieddata.org

This release was published on openPR.